Intra-tumour genetic heterogeneity and poor chemoradiotherapy response in cervical cancer

Abstract

Selection effects from chemoradiotherapy cause dynamic changes in genetic subpopulations in advanced cervical cancers, which may explain disease persistence and subsequent relapse. Significant genetic heterogeneity in advanced cervical cancers may therefore be predictive of poor outcome.